Biosimilars in hematology and oncology /
Cornes, Paul (Oncologist),
Biosimilars in hematology and oncology / [e-book] - 1 online resource (128 pages) : illustrations (black and white, and colour). - Fast facts . - Fast facts. .
Also issued in print: 2020.
Includes bibliographical references and index.
Biologics have revolutionised - and are revolutionising - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars - particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients.
Specialized.
9781912776221 (PDF ebook) : No price No price
Pharmaceutical biotechnology.
Hematology.
Oncology.
Technology, Pharmaceutical.
Hematology.
Medical Oncology.
QV 4
Biosimilars in hematology and oncology / [e-book] - 1 online resource (128 pages) : illustrations (black and white, and colour). - Fast facts . - Fast facts. .
Also issued in print: 2020.
Includes bibliographical references and index.
Biologics have revolutionised - and are revolutionising - the treatment of many serious disorders. The evidence acquired from more than 10 years of clinical experience, with more than 50 biosimilar drugs and more than 700 million patient-days' exposure in Europe, shows that approved biosimilars can be used as safely and effectively as originator biologics. Yet concerns persist about biosimilars - particularly in curative cancer treatment, where they are relatively recent therapeutic options. 'Biosimilars in Hematology and Oncology' provides a concise overview of emerging global practice in this fast-moving area together with practical information on adding biosimilars to a formulary and switching patients.
Specialized.
9781912776221 (PDF ebook) : No price No price
Pharmaceutical biotechnology.
Hematology.
Oncology.
Technology, Pharmaceutical.
Hematology.
Medical Oncology.
QV 4